Tag: the-journal
-
Cancer patients may be overly optimistic about early drug trial participation
By Andrew M. Seaman (Reuters Health) – People with cancer may overestimate the possible benefits to them of participating in an early trial of a new medicine, even after talking with a doctor about what to expect, according to a new study from the U.K. So-called phase 1 trials of experimental treatments are intended to…
-
Kite immunotherapy drug helps blood cancer patients in study
(Reuters) – Kite Pharma Inc on Monday said its experimental CAR T-cell therapy, which helps the immune system fight cancer, was highly effective in treating aggressive non-Hodgkin lymphoma, although two deaths were related to the drug, according to interim data from a midstage trial. Shares of Kite, which had been halted before the release of…
-
More U.S. babies born addicted to opiates like heroin
By Lisa Rapaport (Reuters Health) – The proportion of U.S. babies born suffering from withdrawal syndrome after exposure to heroin or prescription opiates in utero has more than doubled in less than a decade, a study suggests. Researchers focused on what’s known as neonatal abstinence syndrome, a condition akin to withdrawal that develops when babies…
-
Refugee kids face learning challenges in early school years
By Lisa Rapaport (Reuters Health) – Even though some older refugee children may do as well in school as their native-born peers, younger immigrants can still face unique learning challenges in elementary school, a research review suggests. Researchers analyzed data from 34 studies of learning problems in 29 different groups of refugee children and found…